Ohio Board of Pharmacy

Which state pharmacy boards explicitly allow compounding of GLP-1/GIP analogs like tirzepatide and what language do their policies use?

State-level boards generally followed the FDA’s unwind of compounding flexibility: when the FDA declared semaglutide and tirzepatide no longer in shortage it gave 503A pharmacies a limited grace perio...